Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21459735 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients
Condition: Schizophrenia
Interventions: Behavioral: Diet support group;   Behavioral: Group counseling and exercise

Indicates status has not been verified in more than two years